Book a demo

Chemical intelligence powered by cypris.ai

Butiryl-CoA

S-[2-[3-[[4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] butanethioate · also: Butiryl-SCoA, Butiryl-Coenzyme A

FormulaC25H42N7O17P3S
Mol. weight837.6243
PubChem CID439173
InChIKeyCRFNGMNYKDXRTN-XBTRWLRFSA-N
SMILESCCCC(=O)SCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O
58Patents
103Research papers
29Patents - last 3 years
1Papers - last 3 years

Who owns the IP

The organizations most actively patenting around this compound, ranked by referenced patent volume.

#AssigneePatents
1Tata Consultancy Services Ltd4
2Charité – Universitätsmedizin Berlin3
3BayMedica LLC2
4Council of Scientific and Industrial Research2
5Jawaharlal Nehru Centre for Advanced Scientific Research2
6Pendulum Therapeutics Inc2
7Yeda Research and Development Co Ltd2
8Beihang University1
9Braskem SA1
10Institute of Materia Medica, CAMS&PUMC1

Explore the full landscape

This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.

Visit Cypris

Where innovation is concentrated

Patent classifications ranked by volume reveal the technical domains with the most active filing.

#CodeAreaPatents
1C12NMicroorganisms, enzymes40
2C12PFermentation, enzyme processes36
3C12YEnzyme nomenclature (EC numbers)29
4C12R14
5A61KMedicinal preparations12
6Y02EClimate change mitigation: energy10
7A61PTherapeutic activity (drug indications)8
8C07DHeterocyclic compounds7
9A23LFoods and beverages (general)6
10A23KAnimal feeds5

AI mapped opportunity space

This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.

See Cypris in action

Where research is gaining momentum

Research themes ranked by publication activity show where scientific interest is accelerating around this compound.

#Research topicPapers
1Metabolism and Genetic Disorders2
2Liver Disease Diagnosis and Treatment1
3Pharmacological Effects and Toxicity Studies1

Who's driving the science

The most-published authors working with this compound, alongside their primary affiliations.

#AuthorAffiliationPapers
1Kevin A. ReynoldsVirginia Commonwealth University5
2Harry J. FlintUniversity of Aberdeen4
3Petra LouisUniversity of Aberdeen3
4Sandro GhislaUniversity of Konstanz3
5Sang Yup LeeKorea Advanced Institute of Science and Technology3
6Wolfgang BuckelPhilipps University of Marburg3
7Alexander SteinbüchelUniversity of Münster2
8Chaoxuan LiVirginia Commonwealth University1
9Colin ThorpeUniversity of Delaware2
10Cédric Charrier2

Research leaders

This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.

See Cypris in action

The literature that defines it

The most-cited papers anchoring the scientific record for this compound.

Frequently asked questions

Common questions about this compound's patent and research landscape, answered from the underlying data.

What is the molecular formula and weight of Butiryl-CoA?

Butiryl-CoA has the molecular formula C25H42N7O17P3S and a molecular weight of 837.6243 Da. Its canonical name is S-[2-[3-[[4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] butanethioate.

Which patent assignees have filed the most patents related to Butiryl-CoA?

The top patent assignees are Tata Consultancy Services Ltd with 4 patents, followed by Charité – Universitätsmedizin Berlin and BayMedica LLC each with 3 and 2 patents respectively. Other notable assignees include Council of Scientific and Industrial Research, Jawaharlal Nehru Centre for Advanced Scientific Research, Pendulum Therapeutics Inc, and Yeda Research and Development Co Ltd, each holding 2 patents.

What are the primary research topics associated with Butiryl-CoA in the scientific literature?

The primary research topics include Gut microbiota and health, Genomics and Phylogenetic Studies, and Biofuel production and bioconversion. Specific research areas cover the role of butyrate-producing bacteria in the human colon, diversity of colonic microbiota revealed through butyryl-CoA transferase gene analysis, and metabolic pathway reconstruction for n-butanol production.

Which authors have published the most papers on Butiryl-CoA-related research?

Kevin A. Reynolds from Virginia Commonwealth University has published 5 papers, followed by Harry J. Flint from University of Aberdeen with 4 papers. Other prolific authors include Petra Louis from University of Aberdeen, Sandro Ghisla from University of Konstanz, Sang Yup Lee from Korea Advanced Institute of Science and Technology, and Wolfgang Buckel from Philipps University of Marburg, each with 3 papers.

What is the patent landscape trend for Butiryl-CoA in recent years?

Patent activity shows a significant increase in recent years. In 2022, there were 16 patents filed, followed by 15 in 2023 and 12 in 2024. The most common patent classification is C12N with 40 patents, followed by C12P with 36 patents and C12Y with 29 patents, indicating focus on biotechnology, bioprocesses, and enzymatic methods.

Turn any compound into a complete chemical intelligence landscape

Go beyond static compound data. Cypris resolves identities, patents, papers, and commercial signals into one AI-powered view - so your team can move from a single chemical question to a complete R&D, IP, and market landscape.

Schedule a free trial